Rani Therapeutics Holdings, Inc. (RANI)
0.8125
-0.02
(-2.12%)
USD |
NASDAQ |
Apr 07, 16:00
0.82
+0.01
(+0.92%)
After-Hours: 19:44
Rani Therapeutics Holdings EPS Diluted (Quarterly) : -0.0701 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.075M |
| Revenue (Quarterly) | 1.461M |
| Total Expenses (Quarterly) | 11.77M |
| Enterprise Value | 45.69M |
| Gross Profit Margin (Quarterly) | 87.27% |
| Profit Margin (Quarterly) | -621.1% |
| Earnings Yield | -73.08% |
| Normalized Earnings Yield | -72.74 |